Repository corticotropin injection: Interim Phase IIb data

Interim data from an ongoing, open-label Phase IIb trial in 15 patients with Type I or II diabetes and >3,000 mg proteinuria per 24 hours showed that H.P. Acthar Gel for 6 months produced 1 complete r...